Treatment with the phosphatidylinositol 3-kinase inhibitor wortmannin promotes -30% decrease in the steady-state number of cell-surface transferrin receptors. This effect is rapid and dose dependent, with maximal down-regulation elicited within 30 min of treatment and with an IC50 -25 nM wortmannin. Wortmannin-treated cells display an increased endocytic rate constant for transferrin internalization and decreased exocytic rate constants for transferrin recycling. In addition to these effects in vivo, wortmannin is a potent inhibitor (IC50 -15 nM) of a cell-free assay that detects the delivery of endocytosed probes into a common compartment. Inhibition of the in vitro assay involves the inactivation of a membrane-associated factor that can be recruited onto the surface of vesicles from the cytosol. Its effects on the cell-free assay suggest that wortmannin inhibits receptor sorting and/or vesicle budding required for delivery of endocytosed material to "mixing" endosomes. This idea is consistent with morphological changes induced by wortmannin, which include the formation of enlarged transferrincontaining structures and the disruption of the perinuclear endosomal compartment. However, the differential effects of wortmannin, specifically increased transferrin receptor internalization and inhibition of receptor recycling, implicate a role for phosphatidylinositol 3-kinase activity in multiple sorting events in the transferrin receptor's membrane traffic pathway.
INTRODUCTION
The discovery that the yeast VPS34 gene is necessary for sorting and traffic of vacuolar proteins has promoted interest in the role of lipid kinases in membrane traffic (Herman and Emr, 1990; Schu et al., 1993) . Vps34p has both phosphatidylinositol (PI)l-specific vacuolar membrane traffic events in Saccharomyces cerevisiae is suggested. A role for PI 3-kinase activity has also been identified in the endocytic pathway of mammalian cells in studies of platelet-derived growth factor (PDGF) receptor traffic. Although wild-type PDGF receptors are delivered to a juxtanuclear compartment where they are ultimately degraded, mutant PDGF receptors lacking high-affinity binding sites for the SH2 domain of the p85/110 PI 3-kinase complex fail to reach lysosomes and instead become distributed to the cell's periphery (Joly et al., 1994) . Moreover, although lysosomal degradation of the mutant receptors is markedly decreased, internalization of these receptors is only slightly reduced. Thus, the activity of the p85/ 110 PI 3-kinase has been proposed to function in PDGF receptor endocytosis, presumably after initial clathrin-coated vesicle formation and budding, to regulate an activity involved in the fusion, sorting, and traffic of vesicles containing endocytosed material (Joly et al., 1994) . In contrast, the recent cloning of a mammalian homologue of Vps34p has led to speculation that this PI-specific PI 3-kinase may play a role in regulation of endosomal and lysosomal traffic in higher eukaryotes (Volinia et al., 1995) . This prediction is bolstered by the finding that the mammalian Vps34p is found in a complex with a homologue of Vpsl5p (Volinia et al., 1995) , a serine/threonine protein kinase that has been demonstrated to act upstream of Vps34p in the regulation of vacuolar protein sorting in yeast .
The fungal metabolite wortmannin has been useful in further characterizing the role of PI 3-kinases in vesicle traffic. Wortmannin is an irreversible inhibitor that acts in the nanomolar range to block the activity of the p85/pilO PI 3-kinase of mammalian cells (Arcaro and Wymann, 1993; Powis et al., 1994) , as well as the mammalian Vps34p homologue (Volinia et al., 1995) . This inhibitor blocks insulin-stimulated translocation and fusion of vesicles containing glucose transporters with the plasma membrane (Clark et al., 1994; Okada et al., 1994) and the insulin-dependent exocytosis of IGF-2 and transferrin receptors (TfRs) (Sheperd et al., 1995) . Sorting of newly synthesized lysosomal enzymes from the trans-Golgi network to lysosomes (Brown et al., 1995; Davidson, 1995) and transcytosis in polarized epithelial cells (Hansen et al., 1996) are also disrupted by wortmannin. Several recent studies have shown that wortmannin directly affects the endocytic pathway as well ; Joly et al. (1995) demonstrated that wortmannin abolishes ligand-induced degradation of the PDGF receptor, while Clague et al. (1995) characterized the inhibition of fluid phase endocytosis by the drug. Furthermore, Brown et al. (1995) have shown that wortmannin causes a down-regulation of surface mannose 6-phosphate receptors (M6PRs) but does not interfere with receptor internalization.
These studies implicating a PI 3-kinase activity in the regulation of both ligand-induced and fluid-phase endocytosis prompted us to examine the effects of wortmannin on membrane traffic of the constitutively recycling TfR. TfRs deliver iron to cells through a continual cycle that shuttles the ligand Tf between the plasma membrane and endosomal compartments. Internalization of the ligand-receptor complex is initiated via clathrin-coated vesicles, followed by delivery of Tf to the tubulovesicular endosomal network (Geuze et al., 1984) . After dissociation of iron in these acidic compartments, the apoTf-TfR complex is segregated from lysosomally directed molecules to be directed back to the cell surface (Dautry-Varsat et al., 1983; Klausner et al., 1983a) . Recycling receptors such as the TfR and lysosomally targeted ligands and receptors are internalized by the same clathrin-mediated pathway and intermix in common early endosomal compartments (Geuze et al., 1984; Salzman and Maxfield et al., 1988) . However, the pathways of these molecules diverge at sorting endosomes (Yamashiro et al., 1984; Yamashiro and Maxfield, 1987) ; while lysosomally directed molecules are targeted to late endosomes, recycling receptors are sorted to the cell surface from a distinct class of recycling endosomes (Yamashiro et al., 1984) .
Our investigation demonstrates that the PI 3-kinase inhibitor wortmannin interferes with the TfR's membrane traffic pathway at multiple steps. Treatment of K562 cells with the drug induces a 30% decrease in cell-surface TfRs. Receptor down-regulation is associated with increased endocytosis and decreased exocytosis. In addition, wortmannin inhibits a cell-free assay reconstituting intracellular membrane sorting and fusion events. The fungal metabolite also alters the morphology of Tf-containing endosomes in HeLa cells. Thus, a role for PI 3-kinase activity is implicated in several discrete events of TfR traffic, including its recognition and delivery to the cell's interior, and sorting and recycling to the cell surface.
MATERIALS AND METHODS

Materials
Avidin-,B-galactosidase (Av,BGal), biotin-cytochrome C, wortmannin, transferrin (Tf), dithiothreitol, dimethyl sulfoxide (DMSO), pphenylenediamine, and saponin were purchased from Sigma (St. Louis, MO). Rabbit anti-human Tf was purchased from BoehringerMannheim (Indianapolis, IN). Carrier-free 1251 was purchased from Amersham (Arlington Heights, IL). Biotinylated Tf (B-TfO was prepared as previously described (Wessling-Resnick and Braell, 1990 
125I-Tf Binding Assay
Ligand binding studies were performed as previously described (Schonhorn and Wessling-Resnick, 1994) . Briefly, K562 cells were treated with or without 100 nM wortmannin at 37°C in a-MEM containing 7.5% fetal bovine serum for the times indicated in the figure legends. Cells were subsequently chilled on ice, washed three times with ice-cold phosphate-buffered saline (PBS), and then resuspended in ice-cold binding buffer (25 mM (n-[2-hydroxyethyl] piperazine-N'-[2-ethanesulfonic acid] [HEPES], pH 7.4, 150 mM NaCl, 1 mg/ml bovine serum albumin [BSA] ) at 107 cells/ml. Binding reactions were prepared with 200 ,ul aliquots of this cell suspension, 25 ,ul binding buffer containing 5-500 nM 1251I-Tf, and 25 ,ul binding buffer with or without 50 ,LM unlabeled Tf. Samples were incubated at 4°C for 60 min and then pelleted at 14,000 x g for 5 min. Following a brief wash with ice-cold PBS, cell-associated radioactivity was measured using a Beckman 8000 y-counter (Beckman Instruments, Fullerton, CA); the amount of nonspecifically bound 251I-Tf associated in the presence of excess unlabeled Tf was subtracted from samples incubated in the absence of cold ligand to determine the amount of specific 1251-Tf bound (B). To determine the amount of free radiolabeled ligand (F), supernatants from the latter samples were also counted. Scatchard analysis was employed to determine the number of Tf binding sites (Scatchard, 1949) .
The total number of cellular TfRs were determined as described by Klausner et al. (1983b) . Briefly, K562 cells were solubilized in Tris-buffered saline TBS (10 mM Tris, pH 7.4, 150 mM NaCl) containing 0.1% Triton X-100. Fifty microliters of TBS with 125I-Tf (0.5-500 nM) and 50 ,ul of TBS with or without 50 ,uM unlabeled Tf were added to 150 ,ul aliquots of this cell extract. After a 10-min incubation at room temperature, 250 ,ul ice-cold 60% (w/v) ammonium sulfate was added to the binding reactions to precipitate the ligand-receptor complexes. After 5 min on ice, the precipitate was collected by filtration through Whatman GF/C filters and washed three times with 30% ammonium sulfate containing 0.8% BSA. Filters were dried, counted, and specific radioactivity was taken as the difference between radioactivity measured for samples incubated in the absence and presence of unlabeled Tf.
IN/SUR Analysis of Endocytosis
Wortmannin-treated and control K562 cells were washed and resuspended at a concentration of 2 x 107 cells/ml in ice-cold uptake buffer (25 mM HEPES, pH 7.4, 150 mM NaCl, 1 mg/ml BSA, 1 mg/ml glucose). Endocytosis of 125I-Tf was initiated by rapidly mixing 50 ,ul aliquots containing 106 cells with 200 ,ul prewarmed uptake buffer containing 25 nM Tf. Uptake was terminated at the appropriate times (1-20 min) by placing the samples on ice followed by immediate centrifugation. Duplicate samples were quenched in parallel to measure total and internal 1251I-Tf for each timepoint. To determine total cell-associated radioactivity, supernatants were aspirated and the cpm contained in the cell pellets was measured. The amount of internalized ligand (IN) was determined for the duplicate sample of cells, which were also pelleted but then resuspended in 100 ,ul 25 mM HEPES, pH 7.4, 150 mM NaCl. These cells were subsequently washed with 1 ml ice-cold 200 mM acetic acid, 150 mM NaCl (pH 2.7) for 2 min at 4°C to remove surface-bound radiolabel. Samples were immediately centrifuged and washed with PBS; supematants were removed and pellets were counted to determine cell-associated radioactivity. Surface-bound ligand (SUR) was calculated as the difference between total and intracellular cpm measured in parallel samples. The ratio of internalized to surface ligand (IN/SUR) yields a biphasic curve when plotted as a function of time (Wiley and Cunningham, 1982) . The slope of the initial linear portion of the curve (0-5 min) was calculated by linear regression to determine the endocytic rate constant ke.
Kinetic Analysis of Exocytosis
K562 cells were incubated in the presence of 25 nM 1251I-Tf with or without 100 nM wortmannin for 1 h. Cells were pelleted, washed once with ice-cold PBS, and surface-bound 125I-Tf was removed by a brief wash in 2 ml ice-cold 0.2 M acetate, pH 4.6,150 mM NaCl for 2 min. The acid wash was immediately quenched by addition of 48 ml PBS; cells were washed three times with ice-cold PBS, and then resuspended in uptake buffer containing 250 nM unlabeled Tf with or without 100 nM wortmannin. Samples containing 106 cells were incubated at 37°C for 1-60 min to permit Tf recycling, then immediately transferred to ice and washed once in ice-cold PBS. Cellassociated radioactivity was measured as described above.
Semilog plots of the percent cell-associated radioactivity remaining as a function of time were biphasic, indicating that exocytic release occurs from at least two compartments in K562 cells (Snider and Rogers, 1985; Stein and Sussman, 1986; Schonhorn and Wessling-Resnick, 1994) . Assuming recycling from two separate exocytic compartments, the apparent first order rate constants for each were obtained by nonlinear curve fitting (Sigma Plot, Jandel Scientific) to the following equation: y = afekft + asekst , wherein af and a. are the relative amounts of intracellular ligand within each compartment before exocytosis, and kf and k, represent apparent first-order rate constants for each compartment.
Assay Conditions for Monitoring Colocalization of Endocytic Probes In Vitro
Cell-free assays were performed as previously described (WesslingResnick and Braell, 1990) . Post-nuclear supernatants (PNS) were prepared from -4 x 108 K562 cells incubated for 60 min at 20°C in 2 ml uptake buffer (25 mM HEPES, pH 7.4, 150 mM NaCl, 1 mg/ml glucose, 1 mg/ml BSA) containing either 0.5 mg/ml Av3Gal or 100 nM B-Tf. Internalization was quenched by addition of 10 ml ice-cold PBS, and cells were extensively washed in PBS. The cells were then resuspended in three volumes of ice-cold breaking buffer (20 mM HEPES, pH 7.4, 0.1 M KCl, 85 mM sucrose, 20 ,uM EGTA) and broken using a stainless steel ball homogenizer. PNS was collected by centrifugation at 800 x g for 5 min at 4°C. To separate vesicle fractions, PNS was layered over 0.25 M sucrose, 10 mM acetic acid, 10 mM triethanolamine, 1 mM EDTA, adjusted to pH 7.4, and membranes were pelleted onto a cushion of isotonic Nycodenz (Accurate Chemicals, Westbury, NY) by centrifugation at 95,000 rpm for 5 min at 4°C with an RP1OOAT3 rotor in a Sorvall RC M100 microultracentrifuge. Cytosolic fractions were prepared by centrifugation of PNS at 95,000 rpm for 15 min at 4°C using an RP1OOAT2 rotor in the same instrument. For some experiments, cytosol was also desalted on 1 ml G-25 Sephadex spin columns equilibrated with breaking buffer.
In vitro activity supporting vesicle fusion with a common compartment, which results in Av,BGal:B-Tf complex formation, was assayed by co-incubation of 5 ,ul aliquots of PNS or separated vesicle fractions containing Av,BGal and B-Tf in 50 ,ul breaking buffer supplemented with 1 mM MgATP, 100 ,ug/ml creatine kinase, 8 mM phosphocreatine, 10 jig/ml biotin-cytochrome C, and 1 mM dithiothreitol at 37°C for 30 min. The fusion reaction was terminated by addition of 5 ,ul lysis buffer (10% Triton X-100, 1% SDS, 50 ,tug/ml biotin-cytochrome C) and 200 ,ul dilution buffer (0.05% Triton X-100, 50 mM NaCl, 10 mM Tris, pH 7.4, 1 mg/ml heparin); lysates were clarified by centrifugation at 14,000 rpm for 5 min at 4°C in a Eppendorf microcentrifuge. The complex between AvJBGal and B-Tf resulting from their colocalization was measured by a modified enzyme-linked immunoabsorbent assay (Braell, 1987 Figure 1A ). Wortmannin is potent in its effects (IC50 -25 nM; Figure 1B ) and acts rapidly with maximal effects observed within 30 min of exposure to the drug ( Figure 1C) . Although it is possible that the loss of surface TfRs might be due to missorting to lysosomes or to mislocalization of lysosomal hydrolases to TfR-containing endosomes, control experiments confirmed that the total number of cellular Tf binding sites is the same for wortmannin-treated and control cells. Thus, the decrease in cell surface receptor number does not reflect receptor degradation.
Down-regulation of surface TfRs could result from either an increase in the rate of endocytosis or a decrease in the rate of exocytosis. To investigate the effects of wortmannin on endocytosis, uptake of 125I-Tf by K562 cells at 37°C was measured. IN/SUR was plotted as a function of time to determine ke, the endocytic rate constant, from the initial slope of this line (Wiley and Cunningham, 1982) . As shown by the results of Figure 2A , wortmannin promotes an -1.6-fold increase in ke. Values for ke were determined to be 0.160 ± 0.02 and 0.260 ± 0.07 min-' for control and wortmannin-treated K562 cells, respectively (n = 5).
To study the kinetics of TfR exocytosis, K562 cells were loaded with 125I-Tf for 1 h at 370C in the presence or absence of 100 nM wortmannin, washed free of external and surface-bound ligand, and then release of internalized ligand at 370C was monitored in the continued presence or absence of wortmannin. Under these conditions, wortmannin decreases the rate of TfR recycling ( Figure 2B ). Previous studies have documented that exocytosis of Tf from K562 cells is biphasic, suggesting that release occurs from two internal pools of recycling ligand (Snider and Rogers, 1985; Stein and Sussman, 1986; Schonhorn and WesslingResnick, 1994) . Analysis of data from three independent experiments indicates that wortmannin alters the kinetic rate constants determined for Tf exocytosis from both compartments ( Figure 3A that it is necessary to inactivate activity in both frac-10000 tions to block the cell-free assay. A second conclusion is that the wortmannin-sensitive activity associated with the vesicle population is sufficient to support 0 X',-r/, *' u' ' membrane trafficking events in the cell-free assay be-0 10-10 10-8 10-6 cause wortmannin treatment of cytosol alone is without effect.
WORTMANNIN (M)
The data of Figure 4A be reversed by the addition of untreated cytosol, further suggesting that recruitment of wortmannin-sensitive components onto the surface of vesicles is a necessary step for membrane traffic events. This idea is supported by the results of Figure 4B , which demonstrate the concentration-dependent ability of untreated cytosol to restore activity to wortmannintreated vesicles in the cell-free assay. Thus, cytosolic wortmannin-sensitive factors can cycle on and off membranes to engage in the TfR's endocytic pathway but they appear to exert their functional effects at the endocytic vesicle surface.
Wortmannin Selectively Disrupts Endosomal Compartments
To characterize wortmannin's effect on the morphology of endosomes, HeLa cells were utilized because the adherent growth of this cell line facilitates the use of fluorescence microscopy. Figure 5 shows the typical intracellular distribution of Texas Red-Tf after a 45 min internalization period ( Figure 5A ). Structures containing Tf are vesicular in appearance and abundant throughout the cytoplasm with a more concentrated signal in the perinuclear region of the cell. Incubation with wortmannin induces dramatic changes in the morphology of the Tf-containing structures ( Figure  5B ). Cytoplasmic vesicles appear swollen and enlarged and the perinuclear endosomal compartment also appears disrupted and expanded with the formation of highly condensed areas of Tf staining. To verify that wortmannin does not cause dissociation of Tf from the TfR, TfR distribution was compared by indirect immunofluorescence and found to completely overlap with Texas Red-Tf fluorescence ( Figure 5C , compare arrowheads with Figure 5B ). Therefore, in the experiments described below, Texas Red-Tf staining identifies the intracellular distribution of endocytosed TfRs. The structure of the trans-Golgi network (TGN) was evaluated in control and wortmannin-treated (closed circles) or without (open squares) 100 nM wortmannin. PNS and cytosol were then added to fusion reaction mixtures containing ATP and an ATP-regenerating system and incubated at 37°C for the indicated times. Colocalization of the probes due to vesicle fusion with a common compartment is detected by measuring B-Tf-associated f3Gal activity with a fluorescent substrate. Details of this assay may be found in MATERIALS AND METHODS. Shown is the time course of probe colocalization (measured in fluorescence units). The initial rates for control and wortmannin-treated samples were determined to be 12.6 and 4.5 fluorescence unitsmin-', respectively. Data are representative of results obtained in three independent experiments. (B) Dose response to wortmannin. PNS and cytosol fractions were preincubated on ice in the presence of the indicated concentrations of wortmannin; in vitro assays were then performed as described above, with incubation of the reaction mixtures at 37°C for 30 min. Data points are the mean values of the percentage of maximal activity determined in five independent experiments (+ SD). cells by examining staining profiles of the y-subunit of the clathrin-associated AP-1 complex. Figure 6A confirms the intense juxtanuclear staining of the y-subunit due to association of AP-1 complexes with the TGN (Ahle et al., 1988) . As has been previously reported (Robinson and Kreis, 1992) , immunofluorescent staining of AP-1 y-subunit is also observed throughout the periphery of the cell in punctate vesicular structures. Wortmannin treatment does not cause a redistribution of juxtanuclear AP-1 fluorescence, but does cause an overall retraction of the y-subunit staining from the cell's periphery ( Figure 6B ).
Cells were also counterstained with antibodies to the lysosomally associated protein LAMP-1. Figure  7 shows the typical profiles of endocytosed Tf (Figure 7A ) and LAMP-1 (Figure 7B) , demonstrating that the distribution of these two proteins is distinct. LAMP-1 staining is not significantly affected by wortmannin ( Figure 7D ) and does not appear to colocalize in the swollen peripheral endosomes containing Tf ( Figure 7C ).
The distribution of a late endosomal marker, the M6PR, is perturbed by wortmannin as previously reported (Brown et al., 1995) . In control cells, M6PR immunofluorescence is highly concentrated in perinuclear structures restricted to a defined segment of the nuclear circumference, although discrete vesicular elements are also observed in the peripheral cytoplasm ( Figure 8B ). Although some of the Tf and M6PR fluorescence overlaps, a significant fraction of the peripheral Tf-labeled endosomes do not contain any M6PR signal. Wortmannin fragments the highly concentrated juxtanuclear M6PR signal, with staining observed in swollen vesicular elements distributed over the entire nuclear circumference ( Figure 8D ). Similar observations were reported by Brown et al. (1995) for rat clone 9 hepatocytes treated with similar concentrations of wortmannin. However, the majority of swollen, dilated Tf-containing endosomes remain distinct from M6PR-positive structures.
DISCUSSION
Our investigation characterizes pleiotropic effects of wortmannin on the TfR's endocytic pathway in vivo and in vitro including the following: 1) the rapid down-regulation of -30% of K562 cell surface TfRs, 2) an induced increase in the endocytic rate constant, 3) a reduction in the rate of TfR exocytosis, and 4) potent inhibition of colocalization between endocytosed B-Tf and AvfBGal in vitro. These differential effects indicate that wortmannin can perturb membrane traffic of the TfR at multiple steps; for example, increased endocytosis and decreased exocytosis both contribute to the down-regulation of surface receptors. Wortmannin also induces dramatic alterations in the morphology of Vol. 7, March 1996 Tf-containing endocytic compartments in HeLa cells and appears to target elements of the endocytic pathway as noted by changes in the profile of TfR-and M6PR-containing structures corresponding to early and late endosomal compartments, respectively. The observed effects of wortmannin on the cell surface TfR number and endosomal morphology resemble its action on M6PR distribution as reported by Brown et al. (1995) . These investigators observed a down-regulation of surface M6PRs and an increase in TGN-associated receptors over time. It should be noted that in the latter study, the formation of enlarged phase-luscent organelles was observed to be induced by wortmannin. Under the conditions of our study, such vacuoles are not observed. This difference in results could be due either to the lower concentrations of wortmannin used in our experiments (nM versus ,tM levels) or because the concentration of wortmannin required to elicit effects varies from celltype to cell-type (Davidson, 1995) . The fact that early and late endosomal compartments are both affected suggests that wortmannin may interfere with a regulatory step common to both the TfR and M6PR pathways.
Observations drawn from our in vitro experiments may offer some molecular insights into the nature of wortmannin's effects on receptor recycling. We speculate that inhibition of Av,BGal and B-Tf colocalization results from the failure to form cargo vesicles de novo in the presence of the drug. Endocytic probes internalized independently of one another are known to mix in a common endosomal compartment in vivo and in vitro (Braell, 1987; Salzman and Maxfield, 1988; Gruenberg et al., 1989; Wessling-Resnick and Braell, 1990) . However, there is debate as to whether the transfer of material between endosomal compart-,' ments occurs via maturation of these domains (Murr, phy, 1991) .l recruitment of a wortmannin-sensitive cytosolic factor onto the surface of membranes, we favor the latter view. The idea that wortmannin interferes with TfR sorting and vesicle budding is consistent with the activity of the VPS34 gene product, which is known to block traffic from the yeast Golgi at a late sorting step and to regulate endosomal sorting mechanisms (Munn and Riezmann, 1994) . A consequence of the hypothetical inhibition of vesicle budding would be enlarged, swollen, or dilated endosomes, a prediction borne out by the morphology observed in wortmannin-treated cells. A second prediction is that failure to sort the Tf-TfR complex would retard its progress through the exocytic pathway; in fact, a reduced rate of receptor recycling is observed in vivo. Although the proposal that wortmannin disrupts intracellular receptor sorting and vesicle budding is consistent with several of the effects we observe in vivo, the enhanced rate of TfR internalization suggests that early stages of receptor sorting in the endocytic pathway are differentially regulated.
The fact that wortmannin is known to act on multiple protein targets might explain its differential effects on the TfR pathway. For example, recent work has demonstrated that several PI 3-kinase isoforms exist in mammalian cells. The best characterized activity is the p85/110 complex (Carpenter et al., 1990) . A second PI 3-kinase isotype, pilOy, fails to associate with the regulatory p85 subunit, but can be activated by heterotrimeric G protein subunits (Stephens et al., 1994; Stoyanov et al., 1995) . Both of these PI 3-kinases are inhibited by wortmannin in the nM range. A newly discovered mammalian homologue of the yeast Plspecific PI 3-kinase vps34 is also inhibited by low nM levels of wortmannin (Volinia et al., 1995) . Thus, the observations that at least two independent stages of TfR traffic are differentially affected by wortmannin (i.e., increased internalization from the plasma membrane and inhibition of delivery into "mixing" endosomes), may suggest that multiple PI 3-kinase isoforms function in recognition and sorting of the receptor from distinct membrane domains. However, it is also important to note that the effects of wortmannin are not restricted to PI 3-kinases; a PI 4-kinase sensitive to nM levels of the inhibitor has been characterized (Nakanishi et al., 1995) . Both PI 4-kinases and PI 4-P 5-kinases have been implicated in vesicle traffic. PI 4-kinase activity is associated with glucose transporter-containing vesicles that are recruited to the plasma membrane in response to insulin (Del Vecchio et al., 1991) . A PI 4-P 5-kinase has been purified based on its activity to support fusion of secretory granules with the plasma membrane (Hay et al., 1995) . Yeast FAB1 mutants also have revealed that PI 4-P 5-kinase activity is important to maintain vacuolar function (Yamamoto et al., 1995) . Since PI transfer proteins, which function to present PI to inositol kinases, are implicated in the formation of secretory vesicles from the TGN (Ohashi et al. 1995) and in priming secretory vesicles for fusion with the plasma membrane (Hay et al., 1995) , evidence for a general role for phosphory- lated PI lipids in different steps of membrane traffic exists. Further investigation is required to establish the precise targets through which wortmannin's effects on TfR membrane traffic are mediated. Results of these future studies may help to resolve issues surrounding the nature of organelles comprising the endocytic pathway. Note Added in Revision. While this article was under review, Li et al. (1995) reported that wortmannin treatment of TRVb-1 cells decreases TfR endocytosis as well as slowing exocytosis. Wortmannin was also found to inhibit fusion of endosomes derived from BHK cells and J774E macrophages (Li et al., 1995) . In the latter study, addition of activate' p85/110 PI-3 kinase increased endosome fusion. Although, these data support a role for PI 3-kinase in endosome-endosome fusion, it cannot be concluded that the effects of wortmannin on endosome fusion in vitro are due to specific inhibition of the p85/110 kinase. In this regard, Cross et al. (1995) also have recently reported that wortmannin inhibits bombesinstimulated phospholipase A2 (IC50 -2 nM); a previous study indicated that inhibitors of phospholipase A2 activity block fusion of J774E endosomes in vitro (Mayorga et al., 1993) . In fact, addition of purified p85/110 kinase (kindly provided by Drs. L.C. Cantley and C.L. Carpenter) did not reverse the inhibition of in vitro fusion by wortmannin in our hands, similar to observations reported by Jones and Clague (1995) .
